Safety and Efficacy of EXC 001 in Subjects Who Have Participated in Prior Studies of EXC 001

Completed · Phase 2

Conditions studied: Reduction in Severity of Skin Scarring

In brief

The purpose of this study is to provide subjects who participated in prior studies of EXC 001 the opportunity to have their hypertrophic scars surgically revised and treated with EXC 001.

Key facts

Study ID

NCT01494922

Run by

Pfizer

People needed

14

Starts

2011-12-08

Expected to finish

2013-09-10

Last updated by the study team

2021-08-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthy adults who have participated in previous studies of EXC 001.
• Healthy adults who have chosen to have their scars revised.

You may not qualify if…

• Currently pregnant or pregnant during the 6 months prior to inclusion in the study, or breast feeding.
• Participation in another clinical trial within 30 days prior to the start of the study.

Where it is running

• Altus Research — Lake Worth, Florida, United States
• Northwestern University,Division of Plastic Surgery — Chicago, Illinois, United States
• Jewell Plastic Surgery Center — Eugene, Oregon, United States
• Connall Consmetic Surgery — Tualatin, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.